Astonea Labs, a company in the Pharmaceuticals industry, reported revenue of ₹81 crore and net profit of ₹3.00 crore for the March 2026 quarter.
Astonea Labs (BSE: ASTONEALAB) closed at ₹414.00 on 20 Nov 2026, up 191.3% over the past year. Its market capitalisation is ₹435 crore and it trades at 96.3 times earnings.
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.